No Data
Chugai Pharmaceutical Enhances Governance for Sustainable Growth
Nikkei Average Contribution Ranking (Before the Close) ~ The Nikkei Average has fallen for five consecutive days, with SoftBank Group dragging down by about 80 yen with one stock.
As of the close 19 days ago, the number of rising and falling stocks in the Nikkei Average was 79 stocks up, 144 stocks down, and 2 stocks unchanged. The Nikkei Average has declined for 5 consecutive days, finishing the morning trade at 38,708.38 yen, down 373.33 yen (-0.96%) from the previous day (Volume estimated at 1.2 billion 10 million shares). The U.S. stock market on the 18th continued to decline. The Dow Jones Industrial Average fell by 1,123.03 dollars to 42,326.87 dollars, and the Nasdaq dropped by 716.37 points to 19,392.69 points.
Kaiomu --- fell back, announced the extension of the contract period for the basic contract of commissioned research Trade with Chugai Pharmaceutical.
The price fell. After the close of trade on the 18th, it was announced that the contract period of the basic agreement for commissioned research with Chugai Pharmaceutical was extended, but the unfavorable market conditions led to a prevailing selling pressure. The company signed a memorandum of changes to the basic agreement for commissioned research with Chugai Pharmaceutical, further extending the contract period specified in the original contract dated June 30, 2011 (previous extension disclosed on October 18, 2021, until December 31, 2024).
Chiome Bioscience Extends Master Services Agreement With Chugai Pharmaceutical
Moves to adjust positions ahead of the FOMC results.
The Nikkei average fell for four consecutive trading days, ending at 39,081.71 yen, down 282.97 yen (estimated Volume of 2.1 billion 10 million shares). Selling began on the back of declines in major stock indices in the USA market the previous day. During the mid-morning session, it fell to 39,123.32 yen. However, buying on dips and the stability of US stock Futures in the China market and Extended hours trading led to a rise to 39,382.69 yen by the end of the morning session. However, the results of the US Federal Open Market Committee, which will be revealed early tomorrow Japan time, are on the horizon.
Before the central bank events in Japan and the United States, after a round of buying, there is a stalemate.
The Nikkei average declined for three consecutive trading days, ending at 39,364.68 yen, down 92.81 yen (estimated Volume 1.8 billion 90 million shares). Reflecting the flow of tech stocks being bought in the previous day's USA market, buying led the way, primarily focused on Semiconductors-related stocks. The Nikkei average began to rebound and extended upwards to 39,796.22 yen shortly after the start. However, ahead of events from the USA and Japan central banks, including the Federal Open Market Committee (FOMC), momentum for aggressive upward movement was limited, and after the buying activity settled, there were adjustments in holdings leading to Sell.
No Data
